Drugs / Xuanbai Shengmai Decoction
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT07528196 | Aug 2026 → Jun 2027 expected | acute respiratory distress syndrome | Southeast University, China | Not yet recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Xuanbai Shengmai Decoction | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07528196 ↗ |
| Route | Oral | “receive Xuanbai Shengmai Decoction orally” NCT07528196 ↗ |